Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset, expanded ...

Scholar Rock stock rises on optimism for FDA approval of apitegromab in spinal muscular atrophy. Read more here.

While biologics are expected to drive CDMO growth through 2033, foreign exchange rates and tariffs are looming challenges.